We aimed to elucidate the regulatory mechanism by which lncRNA ROR contributes to the progression of breast cancer in connection with MLL1 and TIMP3, with the intention of presenting a theoretical foundation for an enhanced understanding of breast cancer treatment. The gene discussed is KMT2A; the disease is breast cancer.